Blair William & Co. IL Sells 4,112 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Posted by Emily Schoerning on Mar 29th, 2025

Blair William & Co. IL reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 139,754 shares of the exchange traded fund’s stock after selling 4,112 shares during the period. Blair William & Co. IL’s holdings in SPDR S&P Biotech ETF were worth $12,586,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Kohmann Bosshard Financial Services LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth $29,000. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $29,000. Avior Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after acquiring an additional 307 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $38,000. Finally, Bank of Jackson Hole Trust bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $43,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $84.40 on Friday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a market cap of $5.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The firm has a 50 day simple moving average of $89.40 and a 200 day simple moving average of $93.97.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.